✦ LIBER ✦

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine

✍ Scribed by Lorenzo Cohen; Carl de Moor; Patricia A Parker; Robert J Amato

Book ID: 117724185
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 113 KB
Volume: 7
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(01)00182-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Trial of a B7-1 (CD80) Gene Modi

Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

✍ ANTONIA, SCOTT J.; SEIGNE, JOHN; DIAZ, JOSE; MURO-CACHO, CARLOS; EXTERMANN, MART 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 635 KB

1769 A PHASE I TRIAL OF VEGFR1 PEPTIDE V

1769 A PHASE I TRIAL OF VEGFR1 PEPTIDE VACCINES FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Uemura, Hirotsugu; De Velasco, Marco; Yoshimura, Kazuhiro; Nozawa, Masahiro; Min 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

970 ALLOGENEIC GENETICALLY-MODIFIED TUMO

970 ALLOGENEIC GENETICALLY-MODIFIED TUMOR CELL VACCINE (RCC-26/CD80/IL-2) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A PHASE I TRIAL

✍ A. Buchner; H. Pohla; A. Baur; J. Kopp; A. Pezzutto; T. Blankenstein; D. Schende 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Phase II Trial of Suramin in Patients wi

Phase II Trial of Suramin in Patients with Metastatic Renal Cell Carcinoma

✍ Robert Dreicer; David C. Smith; Richard D. Williams; William A. See 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 43 KB

Patient-Specific Vaccines Derived from A

Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma

✍ Dillman, Robert O.; DePriest, Carol; DeLeon, Cristina; Barth, Neil M.; Schwartzb 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 319 KB

Allogeneic Dendritic Cells Fused with Tu

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

✍ Marten, Angela; Renoth, Sabine; Heinicke, Thomas; Albers, Peter; Pauli, Andreas; 📂 Article 📅 2003 🏛 Mary Ann Liebert 🌐 English ⚖ 506 KB